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Abstract
Background: Autogenous vein grafting is widely used in regular bypassing procedures. Due to its
mismatch with the host artery in both mechanical property and geometry, the graft often over
expands under high arterial blood pressure and forms a step-depth where eddy flow develops, thus
causing restenosis, fibrous graft wall, etc. External stents, such as sheaths being used to cuff the
graft, have been introduced to eliminate these mismatches and increase the patency. Although
histological and immunochemical studies have shown some positive effects of the external stent,
the mechanical mismatch under the protection of an external stent remains poorly analyzed.
Methods: In this study, the jugular veins taken from hypercholesterolemic rabbits were
transplanted into the carotid arteries, and non-woven polyglycolic acid (PGA) fabric was used to
fabricate the external stents to study the effect of the biodegradable external stent. Eight weeks
after the operation, the grafts were harvested to perform mechanical tests and histological
examinations. An arc tangent function was suggested to describe the relationship between pressure
and cross-sectional area to analyse the compliance of the graft.
Results: The results from the mechanical tests indicated that grafts either with or without external
stents displayed large compliance in the low-pressure range and were almost inextensible in the
high-pressure range. This was very different from the behavior of the arteries or veins in vivo. The
data from histological tests showed that, with external stents, collagen fibers were more compact,
whilst those in the graft without protection were looser and thicker. No elastic fiber was found in
either kind of grafts. Furthermore, grafts without protection were over-expanded which resulted
in much bigger cross-sectional areas.
Conclusion: The PGA external extent contributes little to the reduction of the mechanical
mismatch between the graft and its host artery while remodeling develops. For the geometric
mismatch, it reduces the cross-section area, therefore matching with the host artery much better.
Although there are some positive effects, conclusively the PGA is not an ideal material for external
stent.
Published: 16 April 2007
BioMedical Engineering OnLine 2007, 6:12 doi:10.1186/1475-925X-6-12
Received: 31 August 2006
Accepted: 16 April 2007
This article is available from: http://www.biomedical-engineering-online.com/content/6/1/12
© 2007 Teng et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
BioMedical Engineering OnLine 2007, 6:12 http://www.biomedical-engineering-online.com/content/6/1/12
Page 2 of 11
(page number not for citation purposes)
Background
Autogenous vein grafting is widely used in regular bypass-
ing procedures in the treatment of ischemia due to occlu-
sive vascular lesions, such as atherosclerosis. However its
patency is limited by progressive intima hyperplasia,
which causes serious clinical problems, needing repeated
angioplasty and graft surgery. Extensive studies have been
carried out for capturing the mechanisms of restenosis.
Currently the mechanical property/compliance and geo-
metric mismatches are regarded as the main factors con-
tributing to graft failure. Due to the poorly developed
venous middle layer, the graft is over-expanded in an arte-
rial environment where the blood pressure is much higher
than that in the vein. The over-expansion induces
extremely high stresses in the venous wall, approximately
5 times those in the artery wall and 140 times those in the
normal vein [1], which definitely damages the living com-
ponents in the venous wall [2-4]. The distension also
leads to a geometrical mismatch around the anastomosis,
where the eddy flow forms [5-7] hence causing disordered
shear stress distribution and long particle residence time.
Limited by these mismatches, vein patency is generally
less good than those of selected arterial grafts, such as
mammary artery [8], the right gastro-epiploic artery [9],
and the radial artery [10], whose mechanical property
meets that of their hosts much better. However, most
arteries are necessary, so available arterial conduits are
very limited. Therefore this generates an interest in look-
ing for approaches to increase the patency of venous
grafts. One of the most efficient is called external stenting
(ES), which was first introduced by Parsonnet et al. [11] by
using a sheath to cuff the vein section to reduce the mis-
match between graft and host. It has been shown that this
protection could preserve the endothelium cells (ECs),
smooth muscle cells (SMCs) and elastic fibers and
increase vasa vasorum [12,13]. It also indicates that the ES
can decrease wall thickness and matrix deposition signifi-
cantly [13-15], prevent atherosclerosis around the anasto-
mosis [16-20] even in hypercholesterolemic animals [15],
and reduce cell apoptosis [3,7,21,22]. Moreover, ES can
not only improve the patency of the normal vein graft, but
also means that varicose and dilated veins can be used
[23,24].
Up to now, investigations on ES have been largely focused
on morphological, histological and immunochemical
aspects, whilst quantitative results of the mechanical
properties of the graft with ES are still little known, partic-
ularly, whether or not the compliance mismatch can be
eliminated, with the degrading of ES remaining unknown.
In this study, the compliance and distensibility of venous
grafts with and without ES were investigated. Studies were
performed on hypercholesterolemic rabbits. The jugular
vein was harvested and implanted into the carotid artery
transpositionally to form an end-to-end graft and exter-
nally stented with a non-woven polyglycolic acid (PGA)
fabric. After 8 weeks the animal was sacrificed. The graft
was harvested for mechanical tests as well as morpholog-
ical and histological examinations.
Methods
Animal model
Twenty-five adult male rabbits, with a weight ranging
from 2.0 to 2.5 kg, were divided into 5 groups at random
(5 per group). One group was given a normal diet, named
as NDG, and the other four groups, named as HSM, HM,
HSH and HH, respectively, were given a hypercholestero-
lemic diet (HD) by the additional of 1 g of cholesterin
powder per day. The grafts from groups HSM and HM
were used for mechanical study, and the grafts from
groups HSH and HH were used for morphological and
histological examinations (Please refer to the Abbrevia-
tions for details of each group). At the beginning of week
0,2,4,8 and12, blood samples were taken from all the rab-
bits from groups NDG and HH to perform total choles-
terol (TC), triglyceride (TG), low density lipoprotein
(LDL) and high density lipoprotein (HDL) examinations
(BIO-RAD3550-UV, Baxter, USA). Rabbits were fasted 12
hours before blood extraction via ear edge vein. At the end
of the 12th week, the grafting operations were carried out
on all hypercholesterolemic animals and external stents
were used for groups HSM and HSH. The diet remained
unchanged after the operation.
Main procedures of the grafting operation
(1). The feeding was stopped 12 hours before the surgery
and the water supply was stopped 4 hours before. The ani-
mal was anaesthetised with 1% nembutal solution (35–
40 mg/kg) and heparinized with a dose of 1 mg/kg. An
additional nembutal solution (5–10 mg/kg) dose was
injected if needed during the operation.
(2). The jugular vein and carotid artery were dissociated
totally by layered incisions. Then the jugular vein, around
3.5 cm in length, was cut and the residual blood was
washed away carefully with saline solution containing
narceine (1 mg/ml) and heparin (1 mg/ml). The blood
flow in the artery was stopped by non-trauma serrefines,
and a section, around 1.5 cm in length, was cut away per-
pendicular to the axial direction. A cuff technive [25,26]
was adopted to make the implantation, which is shown in
Figure 1. Briefly, pass the carotid artery through a 3 mm
length cuff tube (see Figure 1 (a, b)); overturn the end of
the artery to enwrap the cuff tube (see Figure 1 (c)) and tie
with 3-0 silk thread; connect the jugular vein and the
artery by another 3-0 silk thread tie (see Figure 1 (d)). The
connection close to the heart was made first so that air
could be expelled from the vein section and then the distal
end was connected and tied to form an end-to-end graft.
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The cuff tube used here was obtained from polyethylene
infusion tube with a 2.1 mm inner diameter and a 0.25
mm wall thickness, which was strengthened by being
immersed in 90% alcohol solution for 48 hours.
(3). For the groups (HM & HH) without ES, the serrefine
close to the heart and the one at the distal end were
released to reopen the blood flow. The operating area was
then closed in layers with 4# silk thread.
(4). For the groups (HSM & HSH) with ES, when the target
vein was exposed, its outer diameter was measured at both
ends and the middle point to calculate the width of the ES.
The length of the ES had to be sufficent to cover both cuff
tubes. Therefore a rectangular piece of PGA non-woven
fabric (provided by GUNZE LTD, Japan) was made to
wrap the graft and sutured with 6-0 proline line (Johnson
& Johnson Medical LTD., USA). Then the operating area
and wound were closed.
(5). A dose of 0.8-million units of penicillin was adminis-
tered as soon as the operation was completed and 3 days
later. Aspirin was administered at 12.5 mg/kg/day in the
post-operative 4 weeks. The hyper-cholesterolemic diet
was continued on the following day.
Histological test
The animals in groups HSH and HH were used for histo-
logical examinations. 8 weeks after the operation, the
graft, around 3 cm in length, was harvested. Snipping off
0.5 cm-long sections at both ends, the remaining part was
cut into 4 rings and 3 were selected arbitrarily for morpho-
logical and histological examinations: the thickness of the
intima and media was measured by the Leica Qwin image
analysis system (U.K.); victoria blue-ponceaux (VB) was
used to stain elastic fiber and collagen fiber.
Mechanical test
The grafts and the joined arteries (0.5–1 cm) from the ani-
mals in groups HSM and HM were harvested and sub-
merge in ringer solution containing narceine (1 mg/ml)
immediately and preserved at 4°C for mechanical tests.
The non-touched artery and vein (around 3.5 cm) oppo-
site to the graft were also harvested (the arteries were
grouped as HA, and the veins were HV). All vessels were
mounted in an apparatus built in our laboratory (I3A,
Spain) to perform expansion tests in 6 hours after cutting.
A detailed description of the experimental apparatus has
been well presented elsewhere [27,28]. The sensors used
in the apparatus are the following: 1. LVDT (SX 20 ME ×
200, Sensorex, France) for measuring the volume of the
liquid pumped into the specimen; 2. Microliter syringe
(Hamilton, Switzerland); 3. Pressure sensor (TP3, AEP,
Italy) for measuring the pressure; 4. A/D card (NI PCI
6014, National Instrument, USA) for recording the digital
signals.
It has to be pointed out that the graft with protection usu-
ally had many vasa vasorums, so some of the bigger ones
were ligated carefully while those smaller ones were
blocked by dried blood particles from the blood of the
NDG group. The procedures of the expansion test are pre-
sented below.
Main procedures of the mechanical test
(1). The graft was cannulated at both ends until the tips
touched the cuff tubes and then tied with 4# silk thread
twice. The samples were submerged in sodium lactate
ringer's injection (Guangdong Otsuka Pharmaceutical
Schematic drawing of the grafting process (the silk thread is not shown here)Figure 1
Schematic drawing of the grafting process (the silk thread is not shown here).
Vein
Cuff
tube
Artery
(c) (d)(a) (b)
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Co., Ltd.) and the temperature was controlled at 23°C by
a dipped heater.
(2). Once mounted on the holders, the ringer solution
containing blood particles was injected into the graft
through a triple valve until the internal pressure could
maintain at 50 mmHg in 1 minute without obvious
decrease.
(3). The expansion test was performed by injecting the
ringer solution with the microdose syringe. The amount
of injected liquid was monitored by LVDT and the corre-
sponding pressure was recorded continuously. The axial
stretch ratio (λz = L/Lo in which L is the stretched length
and Lo is the length in the load-free state) varied from 1.0
to 1.4 and at each ratio the specimen was mechanically
preconditioned three times. The testing procedure was
repeated 5 times at each ratio and the loading stopped
when the tube began to lose its straight profile. The pres-
sure and volume (p-V) curve was therefore obtained. The
maximum pressure (mp) in each λz is listed in Table 1.
(4). After the mechanical test, the arteries were cut into
rings (around 1 mm in length) and the geometric informa-
tion was recorded to calculate the cross-section area
(Anon-load) in load free state. The compliance of the sys-
tem was measured by replacing the specimen with a rigid
glass tube and it was taken into account in the experimen-
tal data analysis.
Data fitting and statistics
In this study, the compliance rather than the stress-strain
relation of the tissue was used to describe the mechanical
property. This consideration has relevance to the compli-
ance, giving the distensibility directly, which has already
been well characterized clinically. The volume (V) data is
converted into the equivalent cross-section area (Aeq) by
dividing it by the corresponding axial length (L). The rela-
tionship between pressure (p) and dimensionless change
of Aeq was used to describe the compliance of vessel and
graft, which is defined as:
where Δ  is the dimensionless change of Aeq, defined by
in which A0eq denotes the Aeq at zero pressure. Different
vessels display different shapes of p-Δ  curve. For
instance, artery displays an 'S' shape and that of the graft
is convex in the entire pressure range. An arc tangent func-
tion can capture both of these shapes very well. Therefore
it was introduced to fit the experiment data. This approach
was used in a previous study[29].
Δ  = a·arctan (b·p + c) + d
where a, b, c and d are material constants. Substituting Δ
in (3), the compliance (1) results in
An expansion rate is defined in this study to measure the
expansibility of the vessel in a certain pressure range,
in which Apeq denotes the value of Aeq when pressure
equals p. From (Eq.(5)),  reflects the relative expan-
sion rate when pressure changes from p1 to p2.
The data in this study are presented as Mean ± SD. The
comparison between two groups was tested using a Stu-
dent-T test. p > 0.05 was used to indicate there is no statis-
tical difference; 0.01 < p < 0.05 denotes significant
statistical difference (marked with * or #) and p < 0.01
means a highly significant statistical difference (marked
with ** or ##).
Results
Index of blood-fat
The index of blood-fat (TC, TG, HDL and LDL) of the rab-
bits in groups NDG and HH is shown in Table 2. It is clear
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Table 1: Maximum pressure under different axial stretch ratios in different group (mmHg)
group mp (mmHg) λz 1.0 1.1 1.2 1.3 1.4
HA 20 40 80 100 120
HV 10 10 20 30 40
HSM 20 30 80 160 160
HM 50 100 150 180 180
BioMedical Engineering OnLine 2007, 6:12 http://www.biomedical-engineering-online.com/content/6/1/12
Page 5 of 11
(page number not for citation purposes)
that after 4 weeks of HD feeding, the level of blood fat
increases significantly; after 8 weeks, the TC and HDL
could be as much as 10 times higher than those in NDG.
Thus in this study the hypercholesterolemic animal model
is validated.
Expansion rate and compliance
The arc tangent function (3) can fit the p-Δ  data for any
kind of graft with any value of λz. Representatively, the
data from animals of HA1, HV1, HSM1 and HM1 (the
first animal sacrificed in each group) at λz = 1.4, are plot-
ted in Figure 2 with the corresponding regression lines.
The p-Δ  curves of non-touched arteries and veins dis-
play a representative 'S' shape (Figure 2A), especially the
one from artery, while those from grafts are convex in the
entire pressure range (Figure 2B). This difference may be
due to the vein remodeling in the arterial environment.
Figure 2 indicates that the expansibility of the graft is
much smaller than that of the vein. When pressure
increases from 0 to 20 mmHg, Aeq of the vein could
increase more than 10 times (Figure 2A); however, that of
the grafts only increased by about 50–80% (Figure 2B).
Although the expansibility of the graft with ES was better
than the one without protection, it was still much worse
than that of the artery. Figure 2 also shows that for both
vein and graft without ES, Δ  increases only a little when
the pressure is more than 40 mmHg.
The quantitative comparison of expansibility is listed in
Table 3. When pressure increased from 0 to 20 mmHg, Aeq
of the artery increased by about 20%, and was much less
than those of the grafts, which were around 55% and
80%, respectively. This indicated that the wall of the grafts
was quite loose. The expansion of the grafts without ES
mainly appeared in the low pressure range, while when
the pressure varied from 80 to 120 mmHg, Aeq only
changed 0.5 percent. For the graft with ES, η80–120 is about
3%, much lower than that of the artery (around 17%).
Therefore, we can conclude from Table 3 that, in the phys-
iological pressure range (80 to 120 mmHg), grafts with
and without ESs are quite stiff.
Since the artery, vein and graft are nonlinear materials,
their compliances depend on the extra loading. From the
definition (Eq.(4)), the compliance varies with λz and the
transmural pressure. Thus in order to have a complete
analysis, the compliances at different λz and pressure con-
ditions are shown in Figure 3. Generally, for grafts, at any
given λz, their compliances decreased while p increased
(see Figure 3); and with a given p, when λz increased, it
increased initially and then decreased. Due to the 'S' shape
of p-Δ  curve of artery and vein, their shapes of compli-
ance were convex in the pressure range, and for the artery,
the peak point located around 45 mmHg (see graphs in
Figure 3 with λz = 1.2, 1.3 and 1.4), while that of the vein
appeared around p = 5 mmHg (see Figure 4).
According to the conclusion from Table 3 and the values
in Figure 3, the compliance of the grafts in the low pres-
sure range (p < 20 mmHg) is much higher than that in the
high pressure range (p > 20 mmHg). With a given λz, when
the pressure is less than 20 mmHg, the compliance of HM
(without ES) was higher than that of HSM (with ES). Par-
ticularly, in the cases of p ranging from 0 to 5 mmHg, sig-
nificant differences were found between HM and HSM.
However, the decrease of compliance of HM with pressure
was much faster than that of HSM. Therefore, when pres-
sure exceeded 30 mmHg, the compliance of HSM was
higher than that of HM, especially when λz equaled 1.3
and 1.4.
Under the same pressure, the compliance of the vein was
usually 10 times that of the graft (HSM or HM). This
implies that the venous section becomes much stiffer in
order to tolerate much higher loading in the arterial envi-
A
A
A
A
Table 2: The blood-fat level (mmol/L) (in each group n = 5)
Index Group 0-week 2-week 4-week 8-week 12-week
TC NDG 1.67 ± 0.43 1.72 ± 0.45 1.72 ± 0.25 1.98 ± 0.55 2.02 ± 0.58
HH 1.80 ± 0.20 1.88 ± 0.22 2.59 ± 0.76*# 18.57 ± 1.25**## 19.08 ± 1.31**##
TG NDG 1.06 ± 0.31 1.09 ± 0.45 1.11 ± 0.38 1.28 ± 0.35 1.36 ± 0.55
HH 1.09 ± 0.15 1.12 ± 0.11 2.09 ± 0.87*# 3.83 ± 1.75**## 4.07 ± 1.54**##
HDL NDG 0.61 ± 0.20 0.69 ± 0.26 0.65 ± 0.31 0.58 ± 0.17 0.76 ± 0.27
HH 0.53 ± 0.07 0.55 ± 0.09 1.21 ± 0.35*# 2.04 ± 1.11**## 2.12 ± 1.23**##
LDL NDG 0.93 ± 0.21 0.95 ± 0.33 1.01 ± 0.49 0.89 ± 0.27 0.98 ± 0.25
HH 0.94 ± 0.26 1.06 ± 0.24 1.84 ± 0.36*# 14.68 ± 1.42**## 15.13 ± 1.64**##
Asterisk denotes the comparison with 0-week (*: 0.01 < P < 0.05; **: P < 0.01); Derrick denotes the comparison with NDG at the same temporal 
point (#: 0.01 < P < 0.05; ##: P < 0.01).
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ronment. With the protection of the ES, the mechanical
property of HSM was more similar to that of the artery
when this was compared with HM, even though there
were still important differences in compliance (see Figure
3) and expansibility (see Table 3). Therefore at least 8
weeks after the grafting operation, the PGA ES does not
have a significant impact on improving venous mechani-
cal tone to make it similar to its host artery.
Histological test
The change of mechanical behavior due to remodeling
should have a direct relationship with the change of micro
components and structure, which could be examined by
morphological and histological examinations. Numerous
reports indicate that thickening happens during the
remodeling process in grafts both with and without pro-
tection [13,15]. This study showed consistent results (see
Figure 5); the wall of the grafts was much thicker than that
of the vein (there was a significant statistical difference
between HV and HSM/HM). The thickness of HSM was
smaller than that of HM (there was a significant difference
between them). The adventitial thickness of the graft is
excluded in Figure 5 due to the blurred boundary caused
by serious hyperplasy.
In fact, thickening is not detrimental to the graft, which
decreases the high stress induced by the arterial blood
pressure. However, ideal remodeling would be able to
change the microstructure of the wall and finally arterize
the venous graft. Now it is clear that remodeling leads
grafts without protection to having a fibrotic wall, filled
with foam cells, inflammation cells and, more likely to
fail. The purpose of biodegradable ESs is to make remod-
eling develop well and finally eliminate the geometrical
and mechanical mismatches between the vein and the
host artery. However, the results in this study indicate that
PGA ES does not guarantee an ideal remodeling process.
Apart from the thickness of the venous wall, the amount
of elastic fiber and collagen fiber is another important fac-
tor in determining the mechanical property of the vessel
wall. The collagen bundle in HM (without ES) is much
bigger than the one in HSM (with ES), which is shown in
Figure 6, but collagen fiber in HSM is more compact
whilst that in HM is more floppy. Surprisingly we did not
find any elastic fiber, either in HM or in HSM, which was
possibly due to the HD. We found after 8 weeks of HD
feeding that, the elastic fiber in the wall was getting signif-
icantly less and after 12 weeks it almost disappeared (data
and picture are not shown in this paper). However, if nor-
Table 3: The expansion rate in different pressure ranges (λz = 1.4)
HA HSM HM
η0–20 (%) 20.20 ± 8.93 56.40 ± 7.34 82.43 ± 3.73η80–120 (%) 16.55 ± 3.86 2.99 ± 0.92 0.45 ± 0.10
There is significant statistical difference between any two groups (P < 0.01).
Experimental data points and regressed results (λz1.4, data from HA1, HV1, HSM1 and HM1)Figu e 2
Experimental data points and regressed results (λz= 1.4, data from HA1, HV1, HSM1 and HM1).
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Comparison of compliance between grafts with external stent (HSM), without external stent (HM) and artery (HA)Figure 3
Comparison of compliance between grafts with external stent (HSM), without external stent (HM) and artery (HA). (* denotes 
0.01 < P < 0.05; ** for P < 0.01).
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mal vein is used, breakdown elastic fiber could be
observed in the graft without protection, and the ES
would preserve it [13]. The observation in this study
means that the PGA ES does not promote elastin synthesis
in the arterial environment.
The disappearance of elastic fiber may be the reason for
the convex shapes of p-Δ  curve of the grafts (Figure
2(B)), the high expansibility (Table 3) and the high com-
pliance in the low pressure range (Figure 3). It is well
known that in the low pressure range, the load is mainly
undertaken by elastic fiber, and when pressure exceeds a
certain value, (for artery it is around 50 mmHg,) collagen
fibers begin to tighten to provide strength for the wall,
which is the reason of the 'S' shape of the arterial p-Δ
curve (Figure 2(A)). Grafts in this study lacking elastic
fiber could be compared with a tuck net. During the early
period of liquid being pumped in, pressure increases little,
but as long as the volume reaches a certain value, tighting
the collagen fibers, the pressure increases quickly. Thus
the explanation for the mechanical behaviour of the grafts
is the collagen fiberising of the wall.
Discussion
From the foregoing characterization of the compliance
and the micro-component of the wall, we have come to
the conclusion that the PGA ES can improve the venous
graft tone, giving rise to a smaller expansion rate in the
low pressure range and a higher value in the physiological
range (Table 3), a compliance closer to the artery and
more compact collagen in the wall (Figures 6). However,
the compliance of the venous graft with ES is still quite
different from that of the artery. At least 8 weeks after the
operation, the biodegradable PGA ES could not eliminate
the mechanical mismatch between the venous graft and
its host artery. Although we could not extend the validities
of this conclusion for a longer period, (because after 8
weeks the PGA ES had not degraded thoroughly and the
residual part could still be seen), we do not expect the
improvement of graft tone to become similar to the artery
after a longer period of remodeling.
The weakening of ES will allow the venous wall to under-
take more and more loading and this causes tissue remod-
eling. Therefore the degrading property of ES should be
important. According to technological reports from the
provider, the PGA non-woven fabric used in our experi-
ments degrades totally in 15 weeks in the saline solution
in vitro. Actually, we found that after 12 weeks there was
no perceptible remnant in vivo (the data is not shown in
this paper). Despite its importance, the mechanical prop-
erty evolution of ES in vivo is extremely poorly under-
stood. Except for the weakening process, the degradation
product is another important factor. The products of PGA
are CO2 and H2O, which could decrease the local pH and
affect the local tissue, possibly promoting apoptosis.
The PGA we used is quite rigid. The Young's module is
11.371 Mpa, which means it can be regarded as an inex-
tensible material in the physiological pressure range, since
the strain is less than 0.5 × 10-3 under 100 mmHg transmu-
ral pressure. Therefore the PGA ES could not eliminate
mechanical property mismatch initially. Zweep et al. [30]
and Hinrichs et al. [31] indicated that the best ES would
be a microporous, compliant and biodegradable material.
From the mechanical point of view, the PGA non-woven
fabric is too rigid and should not be considered as an ideal
material for ES. Although the PGA ES did not have a sig-
A
A
Thickness of intima and middle layer of HV, HSM and HM (* denotes 0.01 < P < 0.05)Figur  5
Thickness of intima and middle layer of HV, HSM and HM (* 
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nificant impact on eliminating the compliance mismatch,
it strengthened the graft and prevented over expansion,
and finally resulted in a much smaller cross-sectional area.
Table 4 gives a quantitative comparison: the cross-sec-
tional area of HM was around 15 times that of its host
artery and 5 times more than the diameter of the original
vein. On the other hand, that of HSM only increased by
50% compared with the original size. Even though the
geometrical mismatch had not been eliminated by the ES
totally, the blood flow pattern and the shear stress in the
graft with ES are much more uniform, which is usually
regarded as a crucial factor on the function of the EC and
its denudation [32]. In this study we found that EC was
preserved by the ES in comparison with the denudation of
EC and exposure of subendothelial tissue in the grafts
without protection (the pictures from scanning electronic
microscope are not shown here). Without protection, the
venous inner layer could be over stretched by about 3
times under arterial pressure, causing rupture of the joint
between ECs and basilar membrane. Therefore in our
opinion, over-expansion also plays an important role in
the denudation of the EC.
From the reported results, ESs have a quite similar protec-
tion effect, such as preventing hyperplasia in the inner
layer, preserving EC and SMC, regulating the extracellular
matrix, reducing the lipid deposition, stopping the granu-
locyte and macrophage invasion and the formation of
foam cells, and finally improving the bypass patency sig-
nificantly. However Es currently has not been applied
clinically. This is mainly because of the following remain-
ing questions: (1) how the mechanical property of the
graft varies during the remodeling process when different
kinds of ESs are used, (2) what is the long-term outcome,
(3) what is the standard operation process of cuffing, and
(4) what is the ideal material for ES. Further studies to
address these issues would be very useful.
Conclusion
Grafts both with and without ES displayed a large compli-
ance and high expansibility in the low pressure range and
were almost inextensible in the high pressure range, and
such behavior was more prominent in those without ESs.
The collagenous fiberized graft wall and the disappear-
ance of elastic fiber were the key factors leading to this
mechanical behavior. Although the PGA ES reduced the
Table 4: Cross section areas in load free state (mm2)
HA HV HSM HM
Anon-load 1.28 ± 0.11 2.36 ± 0.64 3.87 ± 0.17 18.15 ± 7.91
All groups are much significantly different from each other (P < 0.01).
Collagen fiber in the graft wall (A: without external stent; B: with external stent; Stained with VB, × 200)Figur  6
Collagen fiber in the graft wall (A: without external stent; B: with external stent; Stained with VB, × 200).
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compliance mismatch between graft and host artery, the
gap remained very large after 8 weeks. Therefore from the
mechanical point of view, the PGA non-woven fabric is
not an ideal material for ES. However, its effect is obvious
in reducing the geometrical mismatch, which is important
for the shear stress pattern in the graft.
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